umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Antibodies to mutated citrullinated vimentin (MCV) are a better predictor of disease activity at 24 months in rheumatoid arthritis than antibodies to cyclic citrullinated peptide (CCP).
2006 (English)In: Arthritis and Rheumatism, ISSN 0004-3591, E-ISSN 1529-0131, Vol. 54Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2006. Vol. 54
Identifiers
URN: urn:nbn:se:umu:diva-39101OAI: oai:DiVA.org:umu-39101DiVA: diva2:389236
Note
70th Annual Scientific Meeting of the American-College-of-Rheumatology/41st Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, Washington, DC, NOV 10-15, 2006Available from: 2011-01-19 Created: 2011-01-18 Last updated: 2017-12-11

Open Access in DiVA

No full text

Authority records BETA

Dahlqvist, Solbritt Rantapää

Search in DiVA

By author/editor
Dahlqvist, Solbritt Rantapää
In the same journal
Arthritis and Rheumatism

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 31 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf